

Drug Class: Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA)
Active Substance: Semaglutide
Strength: 5 mg/vial
Form: Lyophilized Powder
Amount: 2 mL Vial
Active Life: ~7 days
Average Dose: 0.25–2.0 mg/week (research only)
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: N/A
Androgenic Rate: N/A
Manufacturer: Peptide Hubs
Laboratory Test: View Result
Semaglutide 5 mg by Peptide Hubs is a high-purity research peptide formulated as a lyophilized powder. It contains 5 mg of Semaglutide per 2 mL vial and is intended strictly for scientific and investigational purposes. As a GLP-1 receptor agonist, Semaglutide is studied for its effects on blood sugar regulation, appetite suppression, and weight loss in metabolic disorder models.
Semaglutide mimics the human GLP-1 hormone, binding to receptors in the pancreas and brain to increase insulin secretion, reduce glucagon release, and slow gastric emptying. These combined actions can lead to reduced food intake and improved glycemic control. As demonstrated in peer-reviewed studies, GLP-1 agonists like Semaglutide show significant promise in obesity and type 2 diabetes research.
Peptide researchers often use Semaglutide to explore the relationship between appetite hormones, weight loss mechanisms, and insulin resistance. The long half-life allows for once-weekly dosing, making it ideal for studies that monitor metabolic changes over time. For synergistic protocols, it is sometimes stacked with GHK-Cu 10 mg to assess regenerative or anti-aging outcomes, or BPC 157 to evaluate recovery in inflammation-prone models.
All Peptide Hubs products, including Semaglutide, are produced in sterile conditions and lab-tested for identity and purity. Each vial is vacuum-sealed to preserve stability during transit. USA-based customers benefit from fast, discreet shipping, making Peptide Hubs' GLP-1 agonists a trusted solution for domestic research labs.
Peptide Hubs is a premier supplier of research peptides in the USA, known for rigorous quality control, transparent testing, and fast customer support. With growing interest in weight loss peptides, this Semaglutide formulation has become a cornerstone in GLP-1 focused research, offering purity and consistency that independent investigators demand.
Semaglutide is studied primarily for its effects on blood sugar regulation and weight management. It acts as a GLP-1 receptor agonist, mimicking incretin hormones.
Store the lyophilized vial in the refrigerator (2–8°C). After reconstitution with bacteriostatic water, it should be used within 30 days and kept refrigerated.
No, Semaglutide is not known to cause liver toxicity. It is a non-androgenic peptide and does not place stress on hepatic function.
The active life of Semaglutide is approximately 7 days, allowing for weekly dosing in research applications.
Please log in to write Semagluitde 5 mg review.
Drug Class: GLP-1 Receptor Agonist
Active Substance: Semaglutide
Strength: 10 mg/vial
Form: Lyophilized Powder
Amount: 2 mL Vial
Active Life: 5–7 days
Average Dose: 0.25–2.0 mg/week
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: None
Androgenic Rate: None
Manufacturer: Stealth Labs
Laboratory Test: View Result
Shipped Without Label!
Drug Class: GLP-1 Receptor Agonist
Active Substance: Semaglutide
Strength: 5 mg/vial
Form: Lyophilized Powder
Amount: 2 mL Vial
Active Life: ~6–7 days
Average Dose: 0.5–2.0 mg per week
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: N/A
Androgenic Rate: N/A
Manufacturer: Dragon Pharma
Laboratory Test: View Result
Drug Class: GLP-1 Receptor Agonist
Active Substance: Semaglutide
Strength: 5 mg/vial
Amount: 2 mL Vial
Active Life: ~7 days
Average Dose: 0.25–2.0 mg per week
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: N/A (peptide-based)
Androgenic Rate: None
Manufacturer: Kalpa Pharmaceuticals